How is Brugada syndrome diagnosed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brugada Syndrome Diagnosis

Brugada syndrome is diagnosed by demonstrating a coved ST-segment elevation ≥2 mm (type 1 morphology) in right precordial leads V1 and/or V2 positioned in the 2nd, 3rd, or 4th intercostal space, occurring either spontaneously or after sodium channel blocker challenge. 1

Electrocardiographic Diagnostic Criteria

  • The type 1 Brugada pattern is the only diagnostic ECG finding and consists of a coved rSr' morphology with ST-segment elevation ≥2 mm followed by a negative T-wave in leads V1-V3. 1, 2

  • High precordial lead placement (2nd and 3rd intercostal spaces) significantly improves detection sensitivity because the characteristic pattern may be missed with standard lead positioning. 1

  • Serial ECG recordings are essential because the type 1 pattern is transient and can fluctuate between normal and abnormal; a single normal ECG does not exclude the diagnosis. 1

  • The ECG pattern may be intermittent and present only during specific triggers including fever, vagotonic states (rest or sleep), or after administration of sodium channel blockers. 3, 4

Sodium Channel Blocker Provocation Testing

  • When baseline ECG shows type 2 or 3 pattern with high clinical suspicion, perform provocation testing with ajmaline (1 mg/kg IV), flecainide (2 mg/kg IV or 300 mg oral), or procainamide in a monitored setting with resuscitation equipment immediately available. 1, 5

  • Terminate the test immediately if ventricular arrhythmias develop, marked QRS widening occurs (>130% of baseline), or type 1 pattern emerges. 1

  • Patients with only drug-induced type 1 pattern have significantly lower risk (annual event rate <1%) compared to those with spontaneous pattern, and this distinction is critical for management decisions. 1

Clinical Context Required for Diagnosis

  • The diagnosis requires the type 1 ECG pattern PLUS at least one of the following clinical criteria: documented ventricular fibrillation or polymorphic ventricular tachycardia, family history of sudden cardiac death <50 years, presence of type 1 ECG in family members, syncope (particularly at rest or during sleep), or aborted cardiac arrest. 3, 2

  • Exclude structural heart disease through echocardiography and other appropriate imaging, as the diagnosis requires absence of structural abnormalities. 3

Key Diagnostic Triggers to Assess

  • Fever is a critical trigger that unmasks the ECG pattern and directly precipitates ventricular fibrillation; specifically ask about arrhythmic events during febrile illnesses. 3, 4, 6

  • Syncope occurring at rest or during sleep (reflecting enhanced vagal tone) is a high-risk symptom that distinguishes intermediate-risk from low-risk patients. 3, 2

  • Exposure to sodium channel blockers, psychotropic medications, certain anesthetics, or cocaine can unmask the pattern and trigger arrhythmias. 1, 4

Genetic Testing Role

  • Genetic testing identifies pathogenic variants in only 20-30% of phenotype-positive individuals, with SCN5A mutations accounting for the majority. 1

  • A negative genetic test does NOT exclude the diagnosis; clinical and electrocardiographic criteria remain paramount. 1

  • Genetic testing is valuable for cascade screening of first-degree relatives to identify at-risk family members, but does not influence individual prognosis or treatment decisions. 1, 6

  • Genotype does not correlate with risk of adverse events; risk stratification must be based on symptoms and clinical findings, not genetic status. 1

Common Diagnostic Pitfalls

  • Do not rely on standard precordial lead placement alone—always repeat with high precordial positioning (2nd-3rd intercostal spaces) to maximize sensitivity. 1

  • Do not dismiss the diagnosis based on a single normal ECG—the pattern is dynamic and requires serial recordings or provocation testing when clinical suspicion is high. 1

  • Do not confuse type 2 or 3 patterns with diagnostic type 1 pattern—only the coved type 1 morphology is diagnostic; types 2 and 3 require pharmacological confirmation. 1

  • Do not overlook the importance of correct lead placement verification—misplaced leads are a common cause of false-positive and false-negative results. 1

References

1
Guideline

Management of Brugada Syndrome Based on ECG Findings

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

2
Guideline

Brugada Syndrome Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

3
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

4
Guideline

Mechanism of Ventricular Tachycardia in Brugada Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the management approach for a patient with Brugada syndrome as indicated by characteristic electrocardiogram (ECG) findings?
What is the management and treatment for Brugada (Brugada syndrome) syndrome?
What is the management and treatment for Brugada syndrome?
What is the management for Brugada syndrome?
Can Brugada syndrome be treated with medication?
How should I evaluate and manage an isolated elevation of serum aspartate aminotransferase (AST)?
Do I need to hold therapeutic unfractionated heparin (IV infusion or subcutaneous) or low‑molecular‑weight heparin before surgery, and what are the recommended timing intervals, especially in patients with impaired renal function or high thrombotic risk?
What is the recommended apixaban dosing regimen for venous thromboembolism prophylaxis after an elective total hip replacement in an adult with normal renal function (creatinine clearance ≥30 mL/min) and no severe hepatic disease?
In a healthy adult Asian patient undergoing a sub‑brow lift, should subcuticular sutures be placed directly opposite the previous exit point or slightly proximal (offset) to it?
What does an AST level greater than ten times the upper limit of normal indicate?
I have a supine diastolic blood pressure of 40‑50 mm Hg that remains low or falls further on standing; what does this indicate and how should it be evaluated and managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question